Search Results

Tideglusib 50mg 50mg  | Purity Not Available

Adooq Bioscience

Tideglusib is a GSK-3 inhibitor currently in phase II clinical trials for the treatment of Alzheimer disease and progressive supranuclear palsy

More Information Supplier Page

Tideglusib 5mg 5mg  | Purity Not Available

Adooq Bioscience

Tideglusib is a GSK-3 inhibitor currently in phase II clinical trials for the treatment of Alzheimer disease and progressive supranuclear palsy

More Information Supplier Page

Tideglusib 25mg 25mg  | Purity Not Available

Adooq Bioscience

Tideglusib is a GSK-3 inhibitor currently in phase II clinical trials for the treatment of Alzheimer disease and progressive supranuclear palsy

More Information Supplier Page

Tolvaptan 25mg 25mg  | Purity Not Available

Adooq Bioscience

Tolvaptan is a selective, competitive arginine vasopressin receptor 2 antagonist with an IC50 of 1.28?M.

More Information Supplier Page

Tolvaptan 5mg 5mg  | Purity Not Available

Adooq Bioscience

Tolvaptan is a selective, competitive arginine vasopressin receptor 2 antagonist with an IC50 of 1.28?M.

More Information Supplier Page